Study of the sensitivity of the model-predicted bone matrix volume fraction fbm after 10 years of postmenopausal osteoporosis progress with respect to a varying anabolic strength parameter λ, computed for an administration regime involving multiple administrations of denosumab, with a constant administration interval Δtden = 9 months and administered doses Dden = 0, mg/kg, mg/kg, and mg/kg.